Author

R. K. Ganju

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

B. Ramaswamy· 2 shared J. Datta· 2 shared M. A. Cherian· 2 shared N. Willingham· 2 shared C. C. Coss· 1 shared C. E. Bennett· 1 shared D. A. Stover· 1 shared D. Stover· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

B. Ramaswamy

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivJan 14, 2022

Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer

J. Datta, N. Willingham, J. Manouchehri…·M. A. Cherian

This study shows that selective ERβ agonists reduce viability of ER+ breast cancer cells and suggest their potential as a therapeutic strategy when combined with ER blockade.

DOI 10.3389/fonc.2022.857590

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivJan 11, 2022

Augmentation of extracellular ATP synergizes with chemotherapy in triple negative breast cancer

J. M. Manouchehri, J. Datta, N. Willingham…·M. A. Cherian

This study shows that increasing extracellular ATP through P2RX channels and inhibiting ATPases enhances chemotherapy effectiveness in triple-negative breast cancer cells.

DOI 10.3389/fonc.2022.855032

humanexperimental assay

𝕏 PostBluesky